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ABSTRACT 
The core message of the present paper is to show how we did to transform indigenous data (Traditional Medicine) into knowledge 
(Science), and then translate knowledge into innovation. The anti-sickle cell anemia activity of Drepanoalpha® could be due to its 
epigenetic modulator effect as revealed by the testimony’s of all patients received the product. Drepanoalpha® reduces the frequency 
of their crises and improves their general state and their hemoglobin level. All the treated patients have normal phenotype if compared 
them to normal individuals and have not made any more crises for more than six months last. Anthocyanins which are the biologically 
active secondary metabolites of this polyherbal formula are well known in the literature for their impact on epigenetic regulation.           
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INTRODUCTION  
Sickle cell disease (SCD) is a genetic disease in which a mutation 
in the gene encoding the human β-globin subunit results in 
replacement of β6 glutamic acid by valine, leading to the 
formation of abnormal hemoglobin, Hb S. Clinical management 
of SCD includes medullar transplantation, repeated blood 
transfusion, the use of hydroxyurea (HU) and anti-malarial 
prophylaxis. Although, these proposed therapies are limited and 
even not efficient or toxic for a long time use [1-5]. Despite the 
fact that HU possesses epigenetic effect in SCD management, the 
drug is toxic [6]. Thus, there is an urgent need to find affordable 
and alternative drugs. Alternative strategy in the management of 
SCD is now focusing on the identification of epigenetic 
modulators agents mainly that from medicinal plants  
The human β-globin gene family located on the chromosome 11 
encodes five genes, ε, Gγ, Aγ, δ and β that are expressed 
sequentially during development. Primitive human embryonic 
erythropoiesis, during which ε-globin is expressed, first occurs in 
the large predominantly nucleated erythroid cells of the yolk sac 
blood islands. During the fetal stage of development, 
hematopoiesis takes place in the fetal liver and produces definitive 
circulating enucleated erythrocytes in which γ-globin 
predominates.  Around the time of birth and post-natally, the bone 
marrow becomes the site of erythropoiesis and the β-globin gene 
becomes highly transcribed, along with a low level of δ-globin 
gene transcription. It is only at this time, after the switch from γ to 
β-globin synthesis, that SCD, manifest [7]. 
Strategies for epigenetic therapy focused on the reactivation of 
fetal γ-globin expression, fueled by the observation that SCD 
patients with more than moderate increases in Hb F levels had 
significantly reduced clinical symptoms [8]. 
EPIGENETIC TAGS AND CHROMATIN STRUCTURE IN 
MAMMALIAN CELLS 
DNA METHYLATION 
Methylation of cytosine in the CpG islands is the most common 
epigenetic modification affecting mammalian DNA. CpGs in the 
promoters of the human β-globin genes are un-methylated in 
erythroblasts at the developmental stages at which they are 
expressed and methylated in erythroblasts that do not express 
them or in other cell types. DNA methylation may be inhibitory 
for transcription, either by direct interference with transcription 
factor binding or, more commonly, through binding by methyl 
cytosine-binding proteins (MCBPs) at methylated CpG; these 
MCBPs can then act to recruit histone modifying 
enzyme-containing co-repressor complexes [7]. 
HISTONE MODIFICATIONS IN CHROMATIN 
Recent finding indicate that the histone N-terminal tails 
protruding from the surface of the nucleosome are subject to a 
variety of covalent modifications such as acetylation and 
methylation. Acetylation of lysine residues in histone tails is 
typically associated with active genes. Such reaction has the 
potential to alter the chromatin fiber since it neutralizes the basic 
charge of lysine residues. While, methylation of lysine residues 
can be associated with active or repressed genes. Histone 
methylation provides recognition sites for the recruitment of 
non-histone proteins and enzymes which affect downstream gene 
function [7].  
PLANT PHENOLICS AS MODULATORS OF 
EPIGENOME 
DEFINITION AND ROLES  
Polyphenols are naturally occurring bioactive compounds 
characterized by the presence of large multiples of phenol 
structural units. They have antioxidant actions, disease prevention 
properties, and therapeutic actions. Polyphenols of several sources 
have shown a modulator effect on epigenetic mechanisms as DNA 
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methylation, histone modifications and posttranscriptional 
regulation by microRNAs, and these mechanisms in turn, can 
modulate the immune system influencing both activation and 
differentiation of multiple cell types involved in the immune 
response. These phytochemical phenols as secondary metabolites 
in plants play key roles in plants as the ultraviolet (UV) 
protectants, wound-healing action, and disease and pest resistance 
[9]. 
CLASSIFICATION OF PLANT PHENOLS  
Phenols of plant origin are broadly divided into three major groups 
such as (i) phenolic acids, (ii) flavonoids, and (iii) non flavonoid 
polyphenols. Flavonoids are further divided into several classes 
including anthocyanins, flavonols, isoflavones and flavanols [10].   
PROPOSED MECHANISMS OF EPIGENETIC 
REGULATION BY PLANT PHENOLICS  
Many mechanisms were proposed in the literature to explain the 
role of phenolics as epigenetic modulators. Indeed, the phenolics 
compounds may regulate the functions of cellular epigenome by 
acting as antioxidants. Phenolics also act as pro-oxidants in 
presence of iron (Fe+2) and oxygen or in concert with oxidase 
enzymes and induce oxidative stress, which may cause the 
modulation of the cellular epigenome through oxidant and 
thiol-redox signaling pathway. They are also known to undergo 
biotransformation into metabolites that is catalyzed by the cellular 
phase-I and phase-II xenobiotic-metabolizing enzymes. It is 
possible that these metabolites regulate the cellular epigenome 
through signaling cascades [11].   
EFFECTS OF ANTHOCYANINS ON THE NF-kB AND 
OTHER SIGNAL TRANSDUCTION PATHWAYS.  
Many studies indicated that the suppression of proinflammatory 
chemokines, growth factors, and adhesion molecules was 
associated with an inhibition of NF-kB activation. NF-kB, is an 
oxidative stress-sensitive transcription factor that controls 
expression of genes involved in the inflammatory response 
(inflammatory mediator). Several NF-kB–related 
proinflammatory chemokines, cytokines, and mediators of 
inflammatory responses were shown to decrease in the plasma of 
humans after consumption of dietary anthocyanins suggesting the 
role of anthocyanins in the inhibition of NF-kB activation. Direct 
inhibition of LPS-induced NF-kB transactivation by anthocyanins 
was observed in human monocytes   [12]. 
DREPANOALPHA® 
Drepanoalpha® is a polyherbal medicine produced through a 
bio-guided based plant selection after eight years of intensive 
advanced laboratory research by the research team of Professor 
Pius T. Mpiana at the University of Kinshasa, Democratic 
Republic of the Congo. Drépanoalpha® possess a significant 
antisickling (normalization rate >80%) and antioxidant activities 
in vitro (ED50= 0.604 ± 0.028µg/mL) and have the medium lethal 
dose (LD50) higher than 4000 mg/kg (in Wistar rat model). The 
product has non-toxic effect on immune cells and blood clotting 
factors. This poly-herbal formulation increases the hemoglobin 
rate in the rats (500-4000 mg/kg bodyweight) and preserves the 
histological architecture of the liver cells compared with the 
control. The aqueous and alcoholic extracts of Drepanoalpha® 
contain phenolic compounds especially anthocyanins as the 
biologically active constituents [13].  
RESULT OF A PILOTE SCALE PRELIMINARY 
CLINICAL TRIAL  
A cohort of 20 voluntary sicklers patients were treated with 
Drepanoalpha® for four week in the Democratic Republic of the 
Congo especially in the Province of “Equateur”: Abumombazi 
hospital (10 patients including one paralyzed), general hospital of 
Mbandaka (02 patients), general hospital of Gemena (02 patients); 
in Kinshasa city: Binza (02 patients), Mont Ngafula (02 patients), 
Mbanza lemba (01 patient), and in Bukavu city (02 patients). All 
these patients are well-known for their hemoglobinopathy status 
as revealed by electrophoresis technique. They have not gone to 
the school for at least a school year; the frequency of the 
drepanocytary crises is recurring.  In human clinical use, this 
nutraceutical is taken three times daily for the treatment of SCD. 
According to testimony’s of all patients received the product, 
Drepanoalpha® reduces the frequency of their crises and improves 
their general state. The oral administration of Drepanoalpha® does 
not induce any signs of toxicity (no side effects). All the treated 
patients have normal phenotype if compared them to normal 
individuals and have not made any more crises for more than six 
months last. 
 
CONCLUSION 
The field of nutrigenomics involves the study of how genes and 
dietary components interact to influence human phenotype. The 
observation discussed in the present paper concerning the possible 
interaction between βS-gene and Drepanoalpha® bioactive 
secondary metabolites revealed that further studies involving the 
clinical evaluation of epigenetic modification induced by such 
nutraceuticals in a large scale randomized trials are needed to 
assess the applicability of this medicinal food in endemic regions.  
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